Impact of cyclosporine A on the progression of ocular surface diseases: treatment efficacy and potential complications
Journal of Medical Microbiology · 2025
DOI: 10.1099/jmm.0.001978 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2025. Verfasst von Gulnara Begimbayeva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Kazakh-Russian Medical University, 71 Torekulov Str., 050000, Almaty, Republic of Kazakhstan. Hauptthemen laut MEDLINE: Cyclosporine, Dry Eye Syndromes, Ophthalmic Solutions, Immunosuppressive Agents. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Eye diseases are widespread all over the world and, if left untreated, can lead to blindness. Hypothesis. The use of 0.05% cyclosporine A (CsA) solution for the treatment of dry eye causes a decrease in discomfort and pain and improves objective measures such as tear film breakdown time, Schirmer test results and Oxford scale scores due to its anti-inflammatory and immunomodulatory properties that contribute to improved tear film stability and tear production.
Aim
This study aimed to investigate the impact of CsA on the progression of ocular surface diseases. Methodology. An experiment was conducted on the basis of the FOCUS ophthalmology centre, Kazakhstan. A group of 100 individuals diagnosed with mild to severe dry eye illness were administered 0.05% CsA eye drops as part of the treatment protocol.
Results
The positive effect is explained by the anti-inflammatory and immunomodulatory effects of CsA. The study showed that the use of 0.05% CsA solution for the treatment of ocular surface disease led to a decrease in discomfort and pain, as well as an improvement in objective measures, including tear film breakdown time, Schirmer test results and Oxford scale scores. The visual analogue scale showed a significant reduction in symptoms, from 6.8 points at baseline to 3.7 points at day 60. In total, 20% of patients reported moderate side effects, such as pain during instillation and redness of the eye surface.
Conclusion
It is concluded that the use of these drops reduced pain, improved patient condition and enhanced indicators such as the visual analogue scale, tear film breakup time, Schirmer test and Oxford scale of corneal and conjunctival staining. This study differs from the previous ones in that it focuses on the efficacy of 0.05% CsA solution in the treatment of dry eye and also examines the spectrum and frequency of side effects, which is not sufficiently covered in previous studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Kazakh-Russian Medical University, 71 Torekulov Str., 050000, Almaty, Republic of Kazakhstan.
- Department of Ophthalmology, Ophthalmological Centre "FOCUS", 450 Seifullin Ave., 050000, Almaty, Republic of Kazakhstan.
Zitieren
APA
Begimbayeva, G., Botabekova, T., Yelikbayeva, A., Voronkova, E., & Kenzhebayeva, K. (2025). Impact of cyclosporine A on the progression of ocular surface diseases: treatment efficacy and potential complications. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001978
Vancouver
Begimbayeva G, Botabekova T, Yelikbayeva A, Voronkova E, Kenzhebayeva K. Impact of cyclosporine A on the progression of ocular surface diseases: treatment efficacy and potential complications. Journal of Medical Microbiology. 2025. doi:10.1099/jmm.0.001978
BibTeX
@article{Begimbayeva2025,
author = {Begimbayeva, Gulnara and Botabekova, Tursunkul and Yelikbayeva, Assel and Voronkova, Ekaterina and Kenzhebayeva, Kamilla},
title = {Impact of cyclosporine A on the progression of ocular surface diseases: treatment efficacy and potential complications},
journal = {Journal of Medical Microbiology},
year = {2025},
doi = {10.1099/jmm.0.001978}
}
EUVIMED